DE69841894D1 - Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion - Google Patents

Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion

Info

Publication number
DE69841894D1
DE69841894D1 DE69841894T DE69841894T DE69841894D1 DE 69841894 D1 DE69841894 D1 DE 69841894D1 DE 69841894 T DE69841894 T DE 69841894T DE 69841894 T DE69841894 T DE 69841894T DE 69841894 D1 DE69841894 D1 DE 69841894D1
Authority
DE
Germany
Prior art keywords
chlamydia pneumoniae
polypeptides
infection
prevention
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841894T
Other languages
English (en)
Inventor
Remy Griffais
Susan K Hoiseth
Robert John Zagursky
Benjamin J Metcalf
Joel A Peek
Banumathi Sankaran
Leah Diane Fletcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Merck Serono Biodevelopment SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Biodevelopment SAS filed Critical Merck Serono Biodevelopment SAS
Application granted granted Critical
Publication of DE69841894D1 publication Critical patent/DE69841894D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69841894T 1997-11-21 1998-11-20 Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion Expired - Lifetime DE69841894D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714673 1997-11-21
US10707898P 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
DE69841894D1 true DE69841894D1 (de) 2010-10-21

Family

ID=9513667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841894T Expired - Lifetime DE69841894D1 (de) 1997-11-21 1998-11-20 Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion

Country Status (6)

Country Link
US (4) US6559294B1 (de)
AT (1) ATE480625T1 (de)
CY (1) CY1106408T1 (de)
DE (1) DE69841894D1 (de)
ES (1) ES2352082T3 (de)
PT (1) PT1032674E (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
AU696941B2 (en) * 1994-07-01 1998-09-24 Rican Limited Helicobacter pylori antigenic protein preparation and immunoassays
EP0909323B1 (de) * 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Bakterioferritin aus helicobacter pylori
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
WO2000032784A1 (en) * 1998-12-01 2000-06-08 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
AU772356B2 (en) * 1998-12-04 2004-04-22 Aventis Pasteur Limited Two-step immunization procedure against chlamydia infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
WO2000039158A1 (en) * 1998-12-23 2000-07-06 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US7297341B1 (en) * 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) * 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000055326A1 (en) * 1999-03-12 2000-09-21 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
EP1177301B1 (de) 1999-05-03 2007-10-10 Sanofi Pasteur Limited Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CN100406469C (zh) * 1999-09-21 2008-07-30 日本烟草产业株式会社 新蛋白质,其编码基因及它们的使用方法
AU1375501A (en) * 1999-11-12 2001-05-30 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
ATE463575T1 (de) * 1999-12-22 2010-04-15 Aventis Pasteur Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
US20020071831A1 (en) * 2000-04-04 2002-06-13 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020082402A1 (en) * 2000-04-04 2002-06-27 Murdin Andrew D. Chlamydia antigens and corresponding DNA fragments and uses thereof
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20040254130A1 (en) * 2000-05-08 2004-12-16 Murdin Andrew D Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA02011587A (es) * 2000-05-23 2004-07-30 Nexell Therapeutics Inc Reactivos para la seleccion de celulas y metodos de uso.
CA2414884A1 (en) * 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae
US7811592B2 (en) * 2000-08-16 2010-10-12 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
DE60142693D1 (de) * 2000-09-08 2010-09-09 Daiichi Sankyo Co Ltd Arzneimittel für herzversagen
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
AU2002234796A1 (en) * 2000-12-14 2002-06-24 Centre National De La Recherche Scientifique - Cnrs Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative
US8206724B2 (en) * 2000-12-15 2012-06-26 Auburn University Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
US20070149474A1 (en) * 2000-12-15 2007-06-28 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
EP1383922A4 (de) * 2001-04-10 2005-03-30 Agensys Inc Nukleinsäure und zugehöriges, für die behandlung und den nachweis von krebs geeignetes protein mit der bezeichnung 158p3d2
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
US20080112965A1 (en) * 2001-10-01 2008-05-15 Aventis Pasteur Limited Chlamydia OMP antigen
WO2003067399A2 (en) * 2002-02-07 2003-08-14 Byington Carrie L Method for creating and using a treatment protocol
CA2523626A1 (en) * 2002-04-26 2003-11-06 Board Of Regents, The University Of Texas System Method and system for the detection of cardiac risk factors
WO2004047759A2 (en) * 2002-11-22 2004-06-10 Wyeth Composition for treating chlamydia infections and method for identifying same
US20040208890A1 (en) * 2003-02-24 2004-10-21 Institut Pasteur Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
WO2004113374A2 (en) * 2003-06-17 2004-12-29 Intercell Ag Chlamydia pneumoniae antigens
US20050042214A1 (en) * 2003-07-15 2005-02-24 Gershwin M. Eric Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
US8101431B2 (en) 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
EP1751300B1 (de) * 2004-05-11 2017-11-08 AbGenomics Coöperatief U.A. T-zelltod induzierende epitope
US20060253097A1 (en) * 2004-10-21 2006-11-09 Braig James R Methods of treating diabetes
JP4874999B2 (ja) * 2005-02-07 2012-02-15 ジェン−プローブ・インコーポレーテッド Ｂ群連鎖球菌属を検出するための組成物及び方法
CA2610793A1 (en) 2005-05-31 2007-05-10 Labnow, Inc. Methods and compositions related to determination and use of white blood cell counts
US7498137B2 (en) * 2005-06-06 2009-03-03 Gen-Probe Incorporated Compositions and methods for determining the presence of Chlamydophila pneumoniae in a test sample
EP1905825A1 (de) * 2006-09-29 2008-04-02 greenovation Biotech GmbH Galactosyltransferase
EP2099482A2 (de) * 2006-12-04 2009-09-16 Auburn University Chlamydia pneumoniae-impfstoff und verfahren zur verabreichung eines derartigen impfstoffes
US20090092969A1 (en) * 2007-10-09 2009-04-09 Michael Aye Detection of atypical pneumonia
US20130071421A1 (en) * 2009-10-02 2013-03-21 W. Ian Lipkin Turkey viral hepatitis virus and uses thereof
US9347944B2 (en) * 2010-03-31 2016-05-24 Yamaguchi Technology Licensing Organization, Ltd. Method for detecting pneumonia causative bacteria using nucleic acid chromatography
KR101311886B1 (ko) 2010-05-26 2013-09-26 한국기초과학지원연구원 폐렴연쇄상구균의 분비단백질을 포함하는 폐렴 진단용 조성물
US20130280167A1 (en) * 2010-10-19 2013-10-24 Moses Rodriguez Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
DK2663579T3 (en) 2011-01-14 2017-07-31 Univ California THERAPEUTIC ANTIBODIES AGAINST ROR-1 PROTEIN AND PROCEDURES FOR USE THEREOF
US9944677B2 (en) 2013-03-15 2018-04-17 Georgetown University Selective inhibitor of angiotensin II
US10835594B2 (en) 2014-01-16 2020-11-17 Mcmaster University Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
CN114137209B (zh) * 2021-02-01 2024-03-01 中国水产科学研究院黄海水产研究所 一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6493591B1 (en) * 2000-07-19 2002-12-10 Medtronic, Inc. Implantable active fixation lead with guidewire tip

Also Published As

Publication number Publication date
US6559294B1 (en) 2003-05-06
US20090274701A1 (en) 2009-11-05
ES2352082T3 (es) 2011-02-15
PT1032674E (pt) 2007-03-30
US7101963B2 (en) 2006-09-05
US20040006218A1 (en) 2004-01-08
CY1106408T1 (el) 2011-10-12
US20070053927A1 (en) 2007-03-08
US7601531B2 (en) 2009-10-13
ATE480625T1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
DE69841894D1 (de) Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
DK1032674T3 (da) Chlamydia pneumoniae genomisk sekvens og polypeptider, fragmenter deraf og anvendelser deraf, især til diagnosen, forebyggelsen og behandlingen af infektion
WO1999028475A3 (en) Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
Sedgley et al. Virulence, phenotype and genotype characteristics of endodontic Enterococcus spp.
DE3588239T3 (de) Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
Myers et al. Isolation and sequence of omcA, a gene encoding a decaheme outer membrane cytochrome c of Shewanella putrefaciens MR-1, and detection of omcA homologs in other strains of S. putrefaciens
WO2003008615A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene
WO2003008602A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene
Fellström et al. Emended descriptions of indole negative and indole positive isolates of Brachyspira (Serpulina) hyodysenteriae
HU196242B (en) Process and reagent combination for identifying microorganisms by sandwich-hybridization of nucleic acids
EP1082465A2 (de) Verfahren zur detektion von mikroorganismen in produkten
RU2673733C2 (ru) Способ амплификации днк на основе внедрения в цепь
Reingold et al. Identification of a new Escherichia coli She haemolysin homolog in avian E. coli
ATE315648T1 (de) Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure
US6391631B1 (en) Bacterial plasmids
US5869642A (en) Detection of the genus pectinatus
WO1990010085A1 (en) Probes, kits and methods for the detection and differentiation of mycobacteria
WO2002024904A2 (de) Verfahren zur herstellung von ribonukleinsäure (rns)
WO2006133758A2 (de) Vorrichtung zur anreicherung/abtrennung von nicht-methylierte cpg-motive enthaltender dna
WO1999016900A1 (de) Verfahren zum identifizieren einer nukleinsäure
Ikehara Possible Application of Entirely New Gene/Protein to Clinical Research
WO1998032862A9 (de) L-alanin dehydrogenase von mycobacterium marinum
JP2008092948A (ja) 検体中の標的核酸を検出するためのキットおよび方法
ATE321862T1 (de) Coryneforme bakterien transformiert mit dem pknd- gen kodierenden nukleotidsequenzen und deren verwendung zur herstellung von l -aminosäuren
GOODING et al. 3. THE DETECTION OF ORGANISMS AT FAMILY, GENUS AND SPECIES LEVEL USING THE POLYMERASE CHAIN REACTION TO AMPLIFY SPECIFIC TARGET DNA SEQUENCES

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SERONO BIODEVELOPMENT SAS, LYON, FR